Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 41, Issue 6

Issues

Type-Specific Detection of Human Papillomaviruses in a Routine Laboratory Setting – Improved Sensitivity and Specificity of PCR and Sequence Analysis Compared to Direct Hybridisation

Siegfried Kösel / Siegfried Burggraf / Jens Mommsen / Werner Engelhardt / Bernhard Olgemöller
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2003.119

Abstract

Human papillomaviruses (HPV) are known to cause cervical dysplasia and cervical carcinoma. We used a 3-step PCR protocol that allows rapid type-specific HPV testing in a routine laboratory setting: HPV-16-positive samples were determined using a specific Light-Cycler PCR; HPV-16-negative samples were amplified by nested PCR and typed by sequence analysis. During a period of 7 months, 1275 PCR-based HPV tests were performed. Of the 1275 samples, 829 samples tested negative for HPV and 446 tested positive, including 124 positives found in the initial HPV-16-specific Light-Cycler assay. Sequence analysis of 132 samples detected 18 HPV types that are not included in the widely used Hybrid Capture II assay. For comparison, the first 100 cervical specimens were tested in parallel using PCR and direct hybridisation (Hybrid Capture II assay). PCR detected HPV DNA in 23 samples that tested negative in the Hybrid Capture assay. Four out of 37 samples that tested positive for HPV in the Hybrid Capture test may be false positives, because sequence analysis detected HPV types not included in the probe mixtures. As rare and novel HPV types may also confer an oncogenic risk, highly sensitive and specific PCR assays will help in understanding cervical HPV infection and cervical cancer of unknown causes.

About the article

Published Online: 2005-06-01

Published in Print: 2003-06-17


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 41, Issue 6, Pages 787–791, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2003.119.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
João Carlos Magi, Elisa Maria da Silva Brito, Elisabete Taeko Onaga Grecco, Sonia Maria Miranda Pereira, and Galdino José Sitonio Formiga
Revista Brasileira de Coloproctologia, 2006, Volume 26, Number 3, Page 233
[2]
Nara de Oliveira Carvalho, Dora Méndez del Castillo, Carlos Perone, José Nélio Januário, Victor Hugo de Melo, and Geraldo Brasileiro Filho
Memórias do Instituto Oswaldo Cruz, 2010, Volume 105, Number 1, Page 73
[3]
Elena Riet Correa Rivero and Fabio Daumas Nunes
Brazilian Oral Research, 2006, Volume 20, Number 1, Page 21
[4]
[5]
Sin Hang Lee, Veronica S Vigliotti, Jessica S Vigliotti, and Suri Pappu
BMC Clinical Pathology, 2009, Volume 9, Number 1
[7]
Elen B Blochin, Kay J Park, Satish K Tickoo, Victor E Reuter, and Hikmat Al-Ahmadie
Modern Pathology, 2012, Volume 25, Number 11, Page 1534
[8]
Mahin Jamshidi, Mohammad Shekari, Abdol Azim Nejatizadeh, Keyanoush Malekzadeh, Mahnaz Baghershiroodi, Parivash Davudian, Farzaneh Dehghan, and Froogh Jamshidi
Archives of Gynecology and Obstetrics, 2012, Volume 286, Number 5, Page 1261
[9]
G. Vecchio, S. Sabella, L. Tagliaferro, P. Menegazzi, M.P. Di Bello, V. Brunetti, R. Cingolani, R. Rinaldi, and P.P. Pompa
Analytical Biochemistry, 2010, Volume 397, Number 1, Page 53
[10]
Sara E. Rosenquist
The Journal of Sexual Medicine, 2012, Volume 9, Number 9, Page 2224
[11]
Marie-Noëlle Didelot-Rousseau, Valérie Courgnaud, Nicolas Nagot, Abdoulaye Ouedraogo, Issouf Konate, Philippe Mayaud, Helen Weiss, Philippe Van de Perre, and Michel Segondy
Journal of Virological Methods, 2006, Volume 135, Number 2, Page 181
[12]
Francesc Alameda, Maria Luisa Mariñoso, Beatriz Bellosillo, Mercè Muset, Silvia Pairet, Imma Soler, Emilia Romero, Fernando Larrazabal, Ramon Carreras, and Sergi Serrano
Tumor Biology, 2011, Volume 32, Number 3, Page 603
[13]
D. HONG, F. YE, H. CHEN, W. LÜ, Q. CHENG, Y. HU, and X. XIE
International Journal of Gynecological Cancer, 2008, Volume 18, Number 1, Page 104
[14]
Yongtaek Oh, Su Mi Bae, Yong-Wan Kim, Ho-Sun Choi, Gye-Hyun Nam, Se-Jun Han, Choong Hak Park, Younglae Cho, Byoung-Don Han, and Woong Shick Ahn
Cancer Science, 2007, Volume 98, Number 4, Page 549
[15]
Andrea L. Fuessel Haws, Sabine Woeber, Miroslava Gomez, Noe Garza, Yvonne Gomez, Peter Rady, Qin He, Lifang Zhang, James J. Grady, Joseph B. McCormick, Susan P. Fisher-Hoch, and Stephen K. Tyring
Journal of Medical Virology, 2005, Volume 77, Number 2, Page 265

Comments (0)

Please log in or register to comment.
Log in